PT  - JOURNAL ARTICLE
AU  - Ziai, Pouya
AU  - Houshmand, Sina
AU  - Salavati, Ali
AU  - Werner, Thomas
AU  - Khiewvan, Benjapa
AU  - Alavi, Abass
TI  - <strong>The evolving role of volumetric PET/CT parameters for prognostication in patients with lung cancer</strong>
DP  - 2015 May 01
TA  - Journal of Nuclear Medicine
PG  - 1912--1912
VI  - 56
IP  - supplement 3
4099  - http://jnm.snmjournals.org/content/56/supplement_3/1912.short
4100  - http://jnm.snmjournals.org/content/56/supplement_3/1912.full
SO  - J Nucl Med2015 May 01; 56
AB  - 1912 Learning Objectives 1. To review and summarize the benefit of PET/CT for prediction of the prognosis and outcome in lung cancer patients 2. To discuss the prognostic value of volumetric PET parameters such as metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in lung cancer patients.Lung cancer is the most common cause of cancer-related deaths in the United States and worldwide. PET/CT has an important role for diagnosis, restaging, treatment planning and evaluating treatment response. Volumetric PET parameters such as MTV and TLG have been shown to be independent biomarkers for prognosis assessment such as predicting overall survival, progression-free survival and disease-free survival as well as response to treatment. In this exhibit, we will discuss following topics: 1. Role of volumetric PET parameters in treatment monitoring, prediction of the treatment outcome and treatment response 2. Value of volumetric PET parameters as prognostic predictor at diagnosis, after induction therapy and for recurrent disease 3. Advantages of volumetric PET parameters over standard uptake value (SUV)